Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation

Wenyi Lu(Tianjin First Center Hospital), Mingfeng Zhao(Nankai University), Hairong Lyu(Tianjin First Center Hospital), Zunmin Zhu(Zhengzhou University), Ting Yuan(Goethe University Frankfurt), Haibo Zhu(Tianjin First Center Hospital), Michael Maschan(Russian Children's Clinical Hospital), Xinping Cao(Tianjin Medical University), Tianle Xie(Nankai University), Alexander G. Gabibov(Institute of Bioorganic Chemistry), Bing Wang(Beijing Forestry University), Yu Zhang(System Simulation (United Kingdom)), Zhao Wang(Capital Medical University), Meng Zhang(Scripps Research Institute), Jiaxi Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongkai Zhang(Nanchang University), Xia Xiao(Hebei Medical University), Xue Bai(Jilin University), А. В. Степанов(Institute of Bioorganic Chemistry), Rui Sun(Nankai University), Juanxia Meng(Nankai University), Haotian Meng(University of Jinan), Yedi Pu(Tianjin First Center Hospital), Yuxin An(Tianjin Medical University), Xiaomei Zhang(Tang Hospital), Xin Jin(Nankai University)
Leukemia
April 17, 2024
10.1038/s41375-024-02251-5
Cited by 11

Related Papers

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
|Blood|2010|430
Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages
|Theranostics|2020|397
A RORγt+ cell instructs gut microbiota-specific Treg cell differentiation
|Nature|2022|253
Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice
|Microbiome|2021|167
First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
|Journal of Hematology & Oncology|2022|149